Prognostic value of YKL-40 in colorectal carcinoma patients: A meta-analysis

doi:10.12998/wjcc.v10.i7.2184

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 7

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4415)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

166

WORD

127

HTML

2130

Figures (1-5)

355

Tables (1-2)

220

Sum=2998

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

309

Download

1108

Sum=1417

Mar 6, 2022 (publication date) through May 29, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Clin Cases. Mar 6, 2022; 10(7): 2184-2193
Published online Mar 6, 2022. doi: 10.12998/wjcc.v10.i7.2184

Full Size Figure Download Figure

Figure 3 The association between YKL-40 and progression-free survival.

Citation: Wang J, Qi S, Zhu YB, Ding L. Prognostic value of YKL-40 in colorectal carcinoma patients: A meta-analysis. World J Clin Cases 2022; 10(7): 2184-2193
URL: https://www.wjgnet.com/2307-8960/full/v10/i7/2184.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i7.2184